Effect of local hyperthermia induced by nanometer magnetic fluid on the rabbit VX2 liver tumor model

Progress in Natural Science

Volumn 19, Issue 12, 2009, Pages 1705-1712

  Du, Lehui ^a,b   Zhou, Jumei ^a,b   Wang, Xiaowen ^b   Sheng, Lin ^c   Wang, Guihua ^a,b   Xie, Xiaoxue ^a,b   Xu, Guoquan ^b,d   Zhao, Lingyun ^b   Liao, Yuping ^a   Tang, Jingtian ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b KEY LABORATORY OF PARTICLE AND RADIATION IMAGING TSINGHUA UNIVERSITY   (China)

^c TSINGHUA UNIVERSITY YUQUAN HOSPITAL   (China)

^d Department of Stomatology of Jia Musi Medical College ^*  (China)

Author keywords

Alternating magnetic field; Hyperthermia; Liver cancer; Magnetic fluid; Rabbit VX2 tumor

Indexed keywords

COMPUTERIZED TOMOGRAPHY; HYPERTHERMIA THERAPY; MAGNETIC FLUIDS; MAGNETITE; NANOMAGNETICS; NANOPARTICLES; WATER INJECTION;

ALTERNATING MAGNETIC FIELD; CONTROL GROUPS; HYPERTHERMIA; INTRATUMORAL INJECTION; LIVER CANCERS; LIVER TUMORS; RABBIT VX2 TUMOR; THERAPEUTIC EFFECTS; TUMOR MODELS; VX2 TUMOR;

TUMORS;

EID: 72749117845     PISSN: 10020071     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnsc.2009.06.006     Document Type: Article

References (52)

1. Tang ZY. Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 2001; 4 (7): 445-54.
2. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42 (5): 1208-36.
3. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362 (9399): 1907-17.
4. Cho YK, Kim JK, Kim MY, et al. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009; 49 (2): 453-9.
5. Narvaez-Lugo J, Caceres WW, Toro DH, et al. Transcatheter arterial chemoembolization and percutaneous ethanol injection for Hepatocellular carcinoma: A retrospective review of the Veterans Affairs Caribbean Healthcare System. Cancer Control 2008; 15 (1): 80-5.
6. Livraghi T. Radiofrequency ablation, PEIT, and TACE for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2003; 10 (1): 67-76.
7. Arimura E, Kotoh K, Nakamuta M, et al. Local recurrence is an important prognostic factor of hepatocellular carcinoma. World J Gastroenterol 2005; 11 (36): 5601-6.
8. Tanaka H, Ueda H, Kida Y, et al. Rapid intrahepatic tumor seeding after percutaneous ethanol injection therapy for hepatocellular carcinoma. Inter Med 2008; 47 (5): 411-4.
9. Shiina S, Teratani T, Obi S, et al. Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 2002; 62 (Suppl.): 64-8.
10. Liu ZC, Tan YK, Jin XJ, et al. Efficacy of percutaneous ethanol injection in treatment of liver cancer. Mod Oncol 2007; 15 (7): 970-2.
11. Vogl TJ, Zangos S, Balzer JO, et al. Transarterial chemoembolization (TACE) in hepatocellular carcinoma: technique, indication and results. Rofo 2007; 179 (11): 1113-2126.
12. Song BC, Chuang YH, Kim JA, et al. Association between insulinlike growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: A prospective study. Cancer 2001; 91 (12): 2386-93.
13. Xiao EH, Li JQ, Huang JF. Effect of preoperative transcatheter arterial chemoembolization on proliferation of hepatocellular carcinoma cells. World J Gastroenterol 2007; 13 (33): 4509-13.
14. Yu Z, Xiaoliang W, Xuman W, et al. Acute toxicity and irritation of water-based dextran-coated magnetic fluid injected in mice. J Biomed Mater Res 2008; 85 (3): 582-7.
15. Wust P, Hildebrandt B, Sreenivasa G, et al. Hyperthermia in combined treatment of cancer. Lancet Oncol 2002; 3 (8): 487-97.
16. Tateishi R, Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 2005; 103 (6): 1201-9.
17. Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: A systematic review. Ann Surg 2009; 249 (1): 20-5.
18. Leyendecker JR, Dodd GD, Halff GA, et al. Sonographically. observed echogenic response during intraoperative radiofrequency ablation of cirrhotic livers: Pathologic correlation. AJR 2002; 178: 1147-51.
19. Ruzzenente A, Manzoni G, Molfetta M, et al. Rapid progression of hepatocellular carcinoma after radiofrequency. World J Gastroenterol 2004; 10 (8): 1137-40.
20. Mulier S, Ni Y, Jamart J, et al. Local recurrence after hepatic radiofrequency coagulation: Multivariate meta-analysis and review of contributing factors. Ann Surg 2005; 242 (2): 158-71.
21. Llovet JM, Vilana R, Bru C, et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001; 33 (5): 1124-9.
22. Frich L, Bjørnland K, Pettersen S, et al. Increased activity of matrix metalloproteinase 2 and 9 after hepatic radiofrequency ablation. J Surg Res 2006; 135 (2): 297-304.
23. Takada Y, Kurata M, Ohkohchi N. Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma. Int J Chin Oncol 2003; 8 (5): 332-5.
24. Ng KK, Lam CM, Poon RT. Portal vein thrombosis after radiofrequency ablation for recurrent hepatocellular carcinoma. Asian J Surg 2003; 26 (1): 50-3.
25. Sutherland LM, Williams J, Padbury R, et al. Radiofrequency ablation of liver tumors: A systematic review. Arch Surg 2006; 141 (2): 181-90.
26. Roayaie S, Haim MB, Emre S, et al. Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: A western experience. Ann Surg Oncol 2007; 10: 764-70.
27. Jordan A, Scholz R, Wust P, et al. Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J Magn Magn Mater 1999; 201 (26): 413-9.
28. Jordan A, Wust P, Fahling H, et al. Inductive heating of ferrimag-netic particles and magnetic fluids: Physical evaluation of their potential for hyperthermia. Int J Hyperthermia 1993; 9 (1): 51-68.
29. Wilhelm C, Fortin JP, Gazeau F. Tumour cell toxicity of intracellular hyperthermia mediated by magnetic nanoparticles. J Nanosci Nano-technol 2007; 7 (8): 2933-7.
30. Jodan A, Wust P, Scholz R, et al. Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro. Int J Hyperthermia 1996; 12 (6): 705-22.
31. Landeghem FK, Maier-Hauff K, Jordan A, et al. Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials 2009; 30 (1): 52-7.
32. Suzuki M, Shinkai M, Honda H, et al. Anticancer effect and immune induction by hyperthermia of malignant melanoma using magnetite cationic liposomes. Melanoma Res 2003; 13 (2): 129-35.
33. Hilger I, Hergt R, Kaiser WA. Use of magnetic nanoparticle heating in the treatment of breast cancer. IEE Proc Nanobiotechnol 2005; 152 (1): 33-9.
34. Johannsen M, Gneveckow U, Eckelt L, et al. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique. Int J Hyperthermia 2005; 21 (7): 637-47.
35. Jordan A, Maier-Hauff K. Magnetic nanoparticles for intracranial thermotherapy. J Nanosci Nanotechnol 2007; 7 (12): 4604-6.
36. Johannsen M, Thiesen B, Jordan A, et al. Magnetic fluid hyperthermia (MFH) reduces prostate cancer growth in the orthotopic Dunning R3327 rat model. Prostate 2005; 64 (3): 283-92.
37. Ito A, Tannka K, Kondo K, et al. Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci 2003; 94 (3): 308-13.
38. Jordan A, Scholz R, Maier-Hauff K, et al. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neurooncol 2006; 78 (1): 7-14.
39. Vulpen M, Raaymakers BW, Lagendijk JJ, et al. Three-dimensional controlled interstitial hyperthermia combined with radiotherapy for locally advanced prostate carcinoma: A feasibility study. Int J Radiat Oncol Biol Phys 2002; 53 (1): 116-26.
40. Moroz P, Jones SK, Gray BN. Tumor response to arterial embolization hyperthermia and direct injection hyperthermia in a rabbit liver tumor model. J Surg Oncol 2002; 80 (3): 149-56.
41. Deger S, Taymoorian K, Boehmer D, et al. Thermoradiotherapy using interstitial self-regulating thermoseeds: An intermediate analysis of a phase II trial. Eur Urol 2004; 45 (5): 574-80.
42. Thiesen B, Jordan A. Clinical applications of magnetic nanoparticles for hyperthermia. Int J Hyperthermia 2008; 24 (6): 467-74.
43. Wust P, Gneveckow U, Johannsen M, et al. Magnetic nanoparticles for interstitial thermotherapy-feasibility, tolerance and achieved temperatures. Int J Hyperthermia 2006; 22 (8): 673-85.
44. Johannsen M, Gneveckow U, Taymoorian K, et al. Thermal therapy of prostate cancer using magnetic nanoparticles. Actas Urol Esp 2007; 31 (6): 660-7.
45. Hilger I, Andra W, Hergt R, et al. Magnetic thermotherapy of breast tumors: an experimental therapeutic approach. Rofo 2005; 177 (4): 507-15.
46. Johannsen M, Gneveckow U, Taymoorian K, et al. Morbidity and quality of life during thermotherapy using magnetic nanoparticles in locally recurrent prostate cancer: Results of a prospective phase I trial. Int J Hyperthermia 2007; 23 (3): 315-23.
47. Hilger I, Hiergeist R, Hergt R, et al. Thermal ablation of tumors using magnetic nanoparticles: An in vivo feasibility study. Invest Radiol 2002; 37 (10): 580-6.
48. Kalambur VS, Longmire EK, Bischof JC, et al. Cellular level loading and heating of superparamagnetic iron oxide nanoparticles. Langmuir 2007; 3 (24): 12329-36.
49. Fortin JP, Gazeau F, Wilhelm C. Intracellular heating of living cells through Neel relaxation of magnetic nanoparticles. Eur Biophys J 2008; 37 (2): 223-8.
50. Jodan A, Wust P, Scholz R, et al. Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo. Int J Hyperthermia 1997; 13 (6): 587-605.
51. Johannsen M, Gneveckow U, Thiesen B, et al. Thermotherapy of prostate cancer using magnetic nanoparticles: Feasibility, imaging, and three-dimensional temperature distribution. Eur Urol 2007; 52 (6): 1653-62.
52. Maier-Hauff K, Rothe R, Scholz R, et al. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: Results of a feasibility study on patients with glioblastoma multiforme. J Neuro-oncol 2007; 81 (1): 53-60.